Session 1: Vaccine Impact Modelling Consortium (VIMC)
Session 2: IA2030 vaccine impact estimates
Session 3: Modelling of Timeliness vs Coverage of Measles Supplementary Immunization Activities (SIAs)
Session 4: Modelling on measles/rubella elimination in South-East Asia
Session 5: Translating vaccine impact modelling into immunization strategy, policy and program decisions
Session 6: Benefit-risk assessment – Dengue vaccine
Session 7: Mathematical modelling of the COVID-19 pandemic according to different vaccination scenarios
in Burkina Faso and Cameroon
Session 8: Therapeutic HPV vaccine impact modelling